ERBB2 and lung carcinoma: While HER2 gene amplification is the primary mechanism responsible for HER2 overexpression in most HER2-positive cancers, except in lung cancer (Ren et al., 2022), high transcription rates of HER2 per gene copy have also been observed to contribute (Liu et al., 2018).